On Thursday, the Food and Drug Administration announced that it has authorized third Pfizer and Moderna shots for certain immunocompromised people, particularly organ transplant recipients and people diagnosed with conditions with “an equivalent level of immunocompromise.” This comes days after a randomized trial in…
